April 10, 2025 — argenx SE (Euronext & Nasdaq: ARGX), a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases, today announced that the U.S. Food and Drug Administration (FDA) approved a…Original Article
Argenx Announces FDA Approval of Vyvgart Hytrulo Prefilled Syringe for Self-Injection
